This study evaluated antibody response to the BNT162B2 vaccine among healthcare workers (HCWs). The authors found that most HCWs had measurable antibodies at 3 months with risk factors for lower antibody levels including older age, male sex, underlying condition, and immunosuppressive treatment.
|